Literature DB >> 18403014

Neuropilin-1 is expressed by chronic lymphocytic leukemia B cells.

Grzegorz S Nowakowski, Debabrata Mukhopadhyay, Xiaosheng Wu, Neil E Kay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403014      PMCID: PMC3440870          DOI: 10.1016/j.leukres.2008.02.020

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  7 in total

1.  Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Authors:  D F Jelinek; R C Tschumper; S M Geyer; N D Bone; G W Dewald; C A Hanson; M J Stenson; T E Witzig; A Tefferi; N E Kay
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

2.  Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.

Authors:  Qi Pan; Yvan Chanthery; Wei-Ching Liang; Scott Stawicki; Judy Mak; Nisha Rathore; Raymond K Tong; Joe Kowalski; Sharon Fong Yee; Glenn Pacheco; Sarajane Ross; Zhiyong Cheng; Jennifer Le Couter; Greg Plowman; Franklin Peale; Alexander W Koch; Yan Wu; Anil Bagri; Marc Tessier-Lavigne; Ryan J Watts
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

Review 3.  The role of neuropilins in cancer.

Authors:  Lee M Ellis
Journal:  Mol Cancer Ther       Date:  2006-05       Impact factor: 6.261

4.  Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia.

Authors:  M Kreuter; K Woelke; R Bieker; C Schliemann; M Steins; T Buechner; W E Berdel; R M Mesters
Journal:  Leukemia       Date:  2006-08-31       Impact factor: 11.528

5.  Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.

Authors:  M Farahani; A T Treweeke; C H Toh; K J Till; R J Harris; J C Cawley; M Zuzel; H Chen
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

6.  VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.

Authors:  Y K Lee; T D Shanafelt; N D Bone; A K Strege; D F Jelinek; N E Kay
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

7.  A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.

Authors:  M P Barr; A M Byrne; A M Duffy; C M Condron; M Devocelle; P Harriott; D J Bouchier-Hayes; J H Harmey
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

  7 in total
  4 in total

Review 1.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

2.  DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.

Authors:  Pooja Jain; Sharrón L Manuel; Zafar K Khan; Jaya Ahuja; Kevin Quann; Brian Wigdahl
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 3.  Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy.

Authors:  Sohini Roy; Arup K Bag; Rakesh K Singh; James E Talmadge; Surinder K Batra; Kaustubh Datta
Journal:  Front Immunol       Date:  2017-10-10       Impact factor: 7.561

4.  Neuropilins: a new target for cancer therapy.

Authors:  Camille Grandclement; Christophe Borg
Journal:  Cancers (Basel)       Date:  2011-04-08       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.